JP2011502121A5 - - Google Patents

Download PDF

Info

Publication number
JP2011502121A5
JP2011502121A5 JP2010531066A JP2010531066A JP2011502121A5 JP 2011502121 A5 JP2011502121 A5 JP 2011502121A5 JP 2010531066 A JP2010531066 A JP 2010531066A JP 2010531066 A JP2010531066 A JP 2010531066A JP 2011502121 A5 JP2011502121 A5 JP 2011502121A5
Authority
JP
Japan
Prior art keywords
peptide
composition
seq
amino acid
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010531066A
Other languages
English (en)
Japanese (ja)
Other versions
JP5379806B2 (ja
JP2011502121A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/012191 external-priority patent/WO2009058244A1/en
Publication of JP2011502121A publication Critical patent/JP2011502121A/ja
Publication of JP2011502121A5 publication Critical patent/JP2011502121A5/ja
Application granted granted Critical
Publication of JP5379806B2 publication Critical patent/JP5379806B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010531066A 2007-10-29 2008-10-28 皮膚の保護ケア用テトラペプチド Active JP5379806B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81507P 2007-10-29 2007-10-29
US61/000,815 2007-10-29
PCT/US2008/012191 WO2009058244A1 (en) 2007-10-29 2008-10-28 Protective skin care tetrapeptides

Publications (3)

Publication Number Publication Date
JP2011502121A JP2011502121A (ja) 2011-01-20
JP2011502121A5 true JP2011502121A5 (https=) 2011-10-13
JP5379806B2 JP5379806B2 (ja) 2013-12-25

Family

ID=40305326

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010531066A Active JP5379806B2 (ja) 2007-10-29 2008-10-28 皮膚の保護ケア用テトラペプチド

Country Status (9)

Country Link
US (1) US8071555B2 (https=)
EP (1) EP2205623B1 (https=)
JP (1) JP5379806B2 (https=)
KR (1) KR101668803B1 (https=)
CN (1) CN101855235B (https=)
CA (1) CA2701420C (https=)
ES (1) ES2567706T3 (https=)
PL (1) PL2205623T3 (https=)
WO (1) WO2009058244A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8168181B2 (en) * 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
CA2822302A1 (en) * 2006-02-13 2007-08-23 Alethia Biotherapeutics Inc. Methods of impairing osteoclast differentiation
ES2421262T3 (es) * 2007-11-30 2013-08-30 Evonik Goldschmidt Gmbh Composición para el cuidado personal y cosmética que contiene tetrapéptidos con las unidades CX1X2G, PX1X2P o PX1X2K
EP2723363B1 (en) 2011-06-24 2018-08-29 NoNO Inc. Combination therapy for ischemia
US9241970B2 (en) * 2011-12-13 2016-01-26 Nono Inc. Therapy for subarachnoid hemorrhage and ischemia
EP2838547B1 (en) * 2012-04-16 2019-09-04 Lubrizol Advanced Materials, Inc. Compounds for the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions
HK1210192A1 (en) 2012-07-19 2016-04-15 Alethia Biotherapeutics Inc. Anti-siglec-15 antibodies
CN105324122B (zh) * 2013-06-14 2019-08-27 赫里克斯生物医疗公司 可用于治疗多种皮肤病的衍生自人类c-x-c趋化因子的四肽
KR20150130616A (ko) * 2014-05-13 2015-11-24 (주)케어젠 피부상태 개선 활성을 갖는 펩타이드 및 이의 용도
US9351911B1 (en) 2015-07-30 2016-05-31 Truth Aesthetics LLC Topical skin care composition providing broad spectrum sunscreen
US9636292B2 (en) 2015-07-30 2017-05-02 Truth Aesthetics LLC Topical skin care composition for night use
CN107629111B (zh) * 2017-10-26 2021-06-04 陕西慧康生物科技有限责任公司 一种乙酰基四肽-2的液相合成方法
CN113166205A (zh) * 2018-11-30 2021-07-23 英特肽治疗有限公司 用于改善皮肤病状的多肽和方法
KR102120992B1 (ko) * 2019-05-03 2020-06-10 (주)위바이오트리 신규한 금속 층상수산화물 복합체 및 이의 제조방법
IT201900008364A1 (it) * 2019-06-07 2020-12-07 Espikem S R L Peptidi bioattivi e composizioni che li comprendono
KR102778423B1 (ko) * 2019-09-26 2025-03-10 (주)아모레퍼시픽 피부 각질세포의 항노화 물질 스크리닝 방법, 스크리닝 키트 및 피부 각질세포의 항노화 물질 함유 조성물
EP4001294A1 (en) * 2020-11-17 2022-05-25 The Boots Company plc Tetrapeptide and compositions comprising tetrapeptides
FR3123193B1 (fr) * 2021-05-28 2025-11-07 Oreal Procédé d’électroporation pour délivrer une composition comprenant au moins un peptide de poids moléculaire allant de 500 Da à 20 kDa
US20250268807A1 (en) * 2022-04-27 2025-08-28 Sbla Brands Inc. Anti-aging peptide containing cosmetic
CN121717873A (zh) * 2026-02-24 2026-03-24 中国医学科学院药用植物研究所 具有祛痘护肤作用的貂肽化合物及其分离制备

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1357121A (en) * 1970-07-28 1974-06-19 Squibb & Sons Inc Peptide enzyme inhibitors
GB2208511A (en) 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
JP2820750B2 (ja) 1988-04-21 1998-11-05 ユーエービー リサーチ ファウンデイション 創傷治療部位における癒着の発生からの保護に適するバイオエラストマー材料
CA2032527C (en) 1989-04-10 2002-07-02 Jesse M. Jaynes Lytic peptides: their use in the treatment of microbial infections, cancer and in the promotion of growth
US5561107A (en) 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
US5464820A (en) 1993-06-22 1995-11-07 The University Hospital Specific inhibitors of tissue kallikrein
US5763576A (en) 1995-10-06 1998-06-09 Georgia Tech Research Corp. Tetrapeptide α-ketoamides
FR2741076B1 (fr) 1995-11-15 1998-01-30 Rech De Pathologie Appliquee S Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
EP0858808B1 (en) 1997-01-17 2003-04-02 Johnson & Johnson Medical Ltd. Peptides for use in wound treatment
GB9702943D0 (en) 1997-02-13 1997-04-02 Univ Manchester Wound healing
SE9701162D0 (sv) 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II
US6143742A (en) 1997-12-11 2000-11-07 Fuisz Technologies Ltd Treatment for necrotizing infections
US6962904B1 (en) 1998-03-13 2005-11-08 Connective Tissue Imagineering Elastin peptide analogs and uses thereof
US6344189B1 (en) 1998-04-01 2002-02-05 Biotech Australia Pty., Ltd. Use of protease inhibitors for treating skin wounds
US6096327A (en) 1998-11-05 2000-08-01 Protease Sciences Inc. Cosmetic compositions containing human type serine protease inhibitors for revitalizing the skin
CA2312075A1 (en) 1998-11-05 2001-12-22 Protease Sciences, Incorporated Cosmetic compositions containing human type serine protease inhibitors
FR2788777B1 (fr) 1999-01-22 2003-01-17 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la regulation des dysfonctionnements immunologiques cutanes et dans l'inflammation cutanee induits par le vieillissement ou par les u.v.
US6492326B1 (en) 1999-04-19 2002-12-10 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
US6284802B1 (en) 1999-04-19 2001-09-04 The Procter & Gamble Company Methods for regulating the condition of mammalian keratinous tissue
CA2276542C (en) 1999-06-28 2013-07-30 Vladislav I. Deigin Novel peptide, a method for its preparation and a pharmaceutical composition containing the peptide
US6967023B1 (en) 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
US6537968B1 (en) 2000-07-24 2003-03-25 Alphamed Pharmaceuticals Corp Treatment of lupus erythematosus
GB0029777D0 (en) 2000-12-06 2001-01-17 Regen Therapeutics Plc Peptides
CA2441562C (en) 2001-03-28 2013-05-14 Helix Biomedix, Inc. Short bioactive peptides and methods for their use
WO2002092623A1 (en) * 2001-05-11 2002-11-21 Research Development Foundation INHIBITORS OF RECEPTOR ACTIVATOR OF NF-κB AND USES THEREOF
US20040167072A1 (en) 2001-05-11 2004-08-26 Aggarwal Bharat B. Inhibitors of receptor activator of NF-kappaB and uses thereof
US7238656B2 (en) 2001-08-29 2007-07-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Protective factors against inflammation, burns and noxious stimuli
US7041506B2 (en) 2001-11-19 2006-05-09 Becton Dickinson And Company Peptides promoting cell adherence, growth and secretion
EP1534308A4 (en) 2001-11-28 2007-03-14 Becton Dickinson Co PEPTIDES WITH INHIBITORY ACTION OF GROWTH
US20040009911A1 (en) 2002-01-31 2004-01-15 Irm, Llc Hepsin substrates and prodrugs
US7491691B2 (en) 2002-05-03 2009-02-17 Sindrey Dennis R Connective tissue stimulating peptides
US7265097B2 (en) 2002-08-20 2007-09-04 Chitogenics, Inc. Methods of drug delivery using sulphated chitinous polymers
US7541440B2 (en) 2002-09-30 2009-06-02 Immunomedics, Inc. Chimeric, human and humanized anti-granulocyte antibodies and methods of use
EP1686957B1 (en) 2003-11-17 2012-03-07 Sederma Compositions containing mixtures of tetrapeptides and tripeptides
DE102004050563A1 (de) 2004-10-15 2006-04-20 Henkel Kgaa Kosmetische und der dermatologische Zusammensetzungen mit Wirkstoffen für einen verbesserten Hautkomfort
DE102005000868A1 (de) 2004-10-15 2006-04-20 Henkel Kgaa Zusammensetzungen mit Inhibitoren der Prostaglandin- und/oder Leukotrien-Synthese in Kombination mit Stimulatoren der Freisetzung kutaner Neuromediatoren
DE202004012807U1 (de) 2004-08-13 2004-10-21 Henkel Kgaa Kosmetische und dermatologische Zusammensetzungen mit DNA-Reparaturenzymen und Oligopeptiden
DE102004055541A1 (de) 2004-11-17 2006-05-18 Henkel Kgaa Kosmetische und dermatologische Zusammensetzungen zur Behandlung reifer Haut
US7271239B2 (en) 2004-09-01 2007-09-18 The Research Foundation Of State University Of New York D-isomers of antimicrobial peptide
WO2006028993A2 (en) 2004-09-02 2006-03-16 Vanderbilt University Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides
US20070224150A1 (en) 2005-03-24 2007-09-27 Yongji Chung Growth factor for hair and skin treatment
FR2884418B1 (fr) 2005-04-15 2008-11-21 Soc Extraction Principes Actif Utilisation d'un peptide comme principe actif amincissant
JP4846799B2 (ja) 2005-07-05 2011-12-28 バイオテンプト ベー．フェー． 腫瘍の治療
US20070077305A1 (en) 2005-10-03 2007-04-05 Le Tien C Biocompatible polymeric matrix and preparation thereof
DE102005063062A1 (de) 2005-12-29 2007-07-05 Henkel Kgaa Synergistische Proteinhydrolysat-Kombinationen zur Behandlung reifer Haut
US7807625B2 (en) 2006-01-18 2010-10-05 Grant Industries, Inc Anti-wrinkle composition
EP2537932B1 (en) * 2006-02-21 2016-04-27 President and Fellows of Harvard College Compositions for and methods of identifying antigens

Similar Documents

Publication Publication Date Title
JP2011502121A5 (https=)
JP2009539987A5 (https=)
JP5379806B2 (ja) 皮膚の保護ケア用テトラペプチド
KR102236805B1 (ko) Hc-ha/ptx3 복합체를 함유하는 조성물 및 이의 사용 방법
Li et al. OM‐LV20, a novel peptide from odorous frog skin, accelerates wound healing in vitro and in vivo
US12269865B2 (en) Recombinant elastin and production thereof
CN101370821B (zh) 新型肽及其用途
AU2014278708B2 (en) Tetrapeptides derived from human C-X-C chemokines useful for treatment of various skin conditions
RU2012103653A (ru) Композиция кожного препарата для наружного применения
CN105273081B (zh) 一种二肽基肽酶iv抑制肽及其制备和应用
KR20220117256A (ko) 펩타이드 및 염증 치료에서의 이의 용도
WO2013042811A1 (ko) 카페오일알파네오엔돌핀 펩타이드 유도체 및 이의 항가려움 및 항아토피 소재로의 활용
JP5342455B2 (ja) 細胞調整及び免疫調整のための短い生物活性ペプチド
JP2013542954A5 (https=)
KR102211099B1 (ko) 기능성 리포펩타이드를 포함하는 피부 개선용 화장료 조성물
WO2024260465A1 (en) New multi-functional oligopeptides
De Oliveira et al. Effect of the leukotriene A4 hydrolase aminopeptidase augmentor 4-methoxydiphenylmethane in a pre-clinical model of pulmonary emphysema
AU2021200731B2 (en) Pro-drug peptide with improved pharmaceutical properties
JPWO2000064926A1 (ja) メラノサイト刺激ホルモン阻害剤
CN117247442B (zh) 蛙属阴离子活性肽及其应用
CN121627874A (zh) 一组乳铁蛋白多肽及其制备和应用
SE0700513L (sv) Kosmetiska kompositioner
HK1146070B (en) Protective skin care tetrapeptides
FR3025428A1 (fr) Composition pharmaceutique stable comprenant du pdgf
HK1217436B (en) Tetrapeptides derived from human c-x-c chemokines useful for treatment of various skin conditions